Requisite Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,920
Closed -$233K 136
2026
Q1
$233K Sell
1,920
-4
-0.2% -$462 0.04% 99
2025
Q4
$204K Sell
1,924
-9,626
-83% -$904K 0.04% 115
2025
Q3
$970K Buy
+11,550
New +$951K 0.16% 49
2024
Q1
Sell
-2,184
Closed -$240K 84
2023
Q4
$240K Sell
2,184
-956
-30% -$99.2K 0.06% 62
2023
Q3
$326K Hold
3,140
0.08% 54
2023
Q2
$365K Hold
3,140
0.09% 47
2023
Q1
$336K Sell
3,140
-415
-12% -$44.8K 0.1% 41
2022
Q4
$397K Hold
3,555
0.13% 34
2022
Q3
$309K Hold
3,555
0.1% 38
2022
Q2
$327K Hold
3,555
0.11% 46
2022
Q1
$294K Buy
3,555
+514
+17% +$40.5K 0.09% 60
2021
Q4
$235K Hold
3,041
0.07% 70
2021
Q3
$230K Buy
3,041
+300
+11% +$22.8K 0.05% 76
2021
Q2
$215K Sell
2,741
-132
-5% -$9.82K 0.04% 76
2021
Q1
$213K Buy
+2,873
New +$212K 0.05% 78
2019
Q2
Sell
-871
Closed -$69K 174
2019
Q1
$69K Buy
+871
New +$65.1K 0.03% 102

Other funds holding MRK

Requisite Capital Management's MRK Position: Q2 2026 in Review

Requisite Capital Management sold out of Merck (MRK) in Q2 2026, closing a stake of 1,920 shares — an estimated $233K sold.

Requisite Capital Management first reported a position in MRK in Q1 2019 and held it in 16 quarters. The position peaked at $970K in Q3 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Requisite Capital Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Requisite Capital Management sold 1,920 Merck shares in Q2 2026, an estimated $233K.
  • Requisite Capital Management first reported a position in Merck in Q1 2019 and held it in 16 quarters.
  • Requisite Capital Management's Merck position peaked at $970K in Q3 2025.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Requisite Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.